A case of severe parkinsonism in an elderly person induced by valproic acid

Psychogeriatrics

Volumn 17, Issue 1, 2017, Pages 76-77

  Tada, Haruka ^a   Ogihara, Tomomi ^a   Nakamura, Toshinori ^a   Sasayama, Daimei ^a   Sugiyama, Nobuhiro ^a   Takahashi, Yuka ^a   Washizuka, Shinsuke ^a   Amano, Naoji ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMMONIA; DONEPEZIL; LEVODOPA; LITHIUM; PEROSPIRONE; VALPROIC ACID; ANTICONVULSIVE AGENT;

AGED; AMMONIA BLOOD LEVEL; BIPOLAR DISORDER; BRAIN DISEASE; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DEPRESSION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; FINGER TREMOR; GAIT DISORDER; HUMAN; LETTER; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; TREATMENT DURATION; TREATMENT FAILURE; VERY ELDERLY; BLOOD; BRAIN; CHEMICALLY INDUCED; DIAGNOSTIC IMAGING; DOSE RESPONSE; PARKINSONIAN DISORDERS; TREATMENT OUTCOME;

AGED; AMANTADINE; ANTICONVULSANTS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PARKINSONIAN DISORDERS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 84954550464     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/psyg.12172     Document Type: Letter

References (6)

1. Jamora D, Lim SH, Pan A, Tan L, Tan EK. Valproate-induced parkinsonism in epilepsy patients. Mov Disord 2007; 22: 130–132.
2. Easterford K, Clough P, Kellett M, Fallon K, Duncan S. Reversible parkinsonism with normal β-CIT-SPECT in patients exposed to sodium valproate. Neurology 2004; 62: 1435–1436.
3. Ristić AJ, Vojvodić N, Janković S, Sindelić A, Sokić D. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia 2006; 47: 2183–2185.
4. Imai Y, Hasegawa K. The Revised Hasegawa's Dementia Scale (HDS-R) – evaluation of its usefulness as a screening test for dementia. J Hong Kong Coll Psychiatr 1994; 4: 20–24.
5. Armon C, Shin C, Miller P, Carwile S, Brown E, Edinger JD, Paul RG. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996; 47: 626–635.
6. Mahmoud F, Tampi RR. Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature. Am J Geriatr Pharmacother 2011; 9: 405–412.